Rhinitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Rhinitis}} | {{Rhinitis}} | ||
{{CMG}} | {{CMG}} {{AE}} {{FB}} | ||
==Overview== | ==Overview== | ||
Rhinitis is a heterogegeous disorder that is often undertreated or overlooked( PMID 11449200) | Rhinitis is a heterogegeous disorder that is often undertreated or overlooked( PMID 11449200) | ||
| Line 10: | Line 10: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 22:04, 23 January 2017
|
Rhinitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhinitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Rhinitis medical therapy |
|
Risk calculators and risk factors for Rhinitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis is a heterogegeous disorder that is often undertreated or overlooked( PMID 11449200)